LY2886721
| CAS No. | 1262036-50-9 | Cat. No. | BCP02507 |
| Name | LY2886721 | ||
| Synonyms | LY 2886721;LY-2886721; | ||
| Formula | C18H16F2N4O2S | M. Wt | 390.41 |
| Description | LY2886721 is an oral, small molecule of β-site amyloid protein cleaving enzyme (BACE) inhibitor with the potential to inhibit the synthesis of β-amyloid and thereby to slow the clinical progression of AD. LY2886721 can also targetγ-secretase to nhibit the synthesis of β-amyloid. | ||
| Pathways | Neuro Signaling Pathway | ||
| Targets | Beta secretase | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.